FGAM
AXSM icon

Financial Gravity Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Financial Gravity Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4
Closed -$306 – 1520
2024
Q1 		$306 Buy
+4
New +$336 ﹤0.01% 1526
2023
Q4 		– Hold
0
– – – 1249
2023
Q3 		– Sell
-72
Closed -$5.38K – 1051
2023
Q2 		$151 Buy
72
+10
+16% +$738 ﹤0.01% 1231
2023
Q1 		$50 Sell
62
-15
-19% -$985 ﹤0.01% 728
2022
Q4 		$155 Sell
77
-58
-43% -$3.47K ﹤0.01% 1033
2022
Q3 		$36 Buy
+135
New +$6.75K ﹤0.01% 675
2021
Q4 		– Sell
-1
Closed -$33K – 964
2021
Q3 		$33K Hold
1
– – 0.02% 682
2021
Q2 		$67K Buy
+1
New +$60 0.02% 472

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return